Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Mbah, Glory Enjong ^a   Ayiseh, Rene Bilingwe ^a   Cho Ngwa, Fidelis ^a  

^a UNIVERSITY OF BUEA   (Cameroon)

Author keywords

Drug screens; Hamsters; Loa; Onchocerca ochengi; Onchocerciasis

Indexed keywords

IVERMECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DISEASE DURATION; DISEASE MODEL; DRUG DOSE COMPARISON; DRUG SCREENING; EAR LOBE; FEMALE; HAMSTER MODEL; INFECTION SENSITIVITY; LOA LOA; LOIASIS; MALE; MICROFILARIA (NEMATODE LARVA); MOUSE; NONHUMAN; ONCHOCERCA; ONCHOCERCA OCHENGI; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASITE CLEARANCE; PARASITE LOAD; SKIN; SPECIES COMPARISON; SYRIAN HAMSTER; VALIDATION STUDY; ANIMAL; HAMSTER; INTRAPERITONEAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; LOA; PATHOGENICITY; PRECLINICAL STUDY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CRICETINAE; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; IVERMECTIN; LOA; MALE; MICE; MICE, INBRED BALB C; ONCHOCERCA; ONCHOCERCIASIS;

EID: 84991826511     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1753-2     Document Type: Article

References (32)

1. Fenwick A. The global burden of neglected tropical diseases. Public Health. 2012;126(3):233-6. doi:10.1016/j.puhe.2011.11.015.
2. Coffeng LE, Stolk WA, Zouré HGM, Veerman JL, Agblewonu KB, Murdoch ME, et al. African programme for onchocerciasis control 1995-2015: updated health impact estimates based on new disability weights. PLoS Negl Trop Dis. 2014;8(6):e2759. doi:10.1371/journal.pntd.0002759.
3. Babalola OE. Ocular onchocerciasis: current management and future prospects. Clin Ophthalmol. 2011;5:1479-91. doi:10.2147/opth.s8372.
4. Burnham G. Onchocerciasis. Lancet. 1998;351(9112):1341-6. doi:10.1016/s0140-6736(97)12450-3.
5. Pearlman E, Lass JH, Bardenstein DS, Kopf M, Hazlett Jr FE, Diaconu E, et al. Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness). J Exp Med. 1995;182(4): 931-40.
6. Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, Boussinesq M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet. 1997;350(9070): 18-22. doi:10.1016/s0140-6736(96)11094-1.
7. Taylor MJ, Awadzi K, Basanez MG, Biritwum N, Boakye D, Boatin B, et al. Onchocerciasis control: vision for the Future from a Ghanian perspective. Parasit Vectors. 2009;2(1):7. doi:10.1186/1756-3305-2-7.
8. Osei-Atweneboana MY, Awadzi K, Attah SK, Boakye DA, Gyapong JO, Prichard RK. Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. PLoS Negl Trop Dis. 2011;5(3):e998.
9. Bianco AE. Onchocerciasis-river blindness. In: MacPherson CNL, Craig PS, editors. Parasitic helminths, zoonoses and human health in Africa. London: Unwin Hyman Press; 1991. p. 138-203.
10. Townson S, Dobinson A, Connelly C, Muller R. Chemotherapy of Onchocerca lienalis microfilariae in mice: a model for the evaluation of novel compounds for the treatment of onchocerciasis. J Helminthol. 1988;62(03): 181-94. doi:10.1017/S0022149X00011494.
11. Townson S, Bianco AE. Experimental infection of mice with the microfilariae of Onchocerca lienalis. Parasitology. 1982;85(Pt 2):283-93.
12. Folkard SG, Taylor MJ, Butcher GA, Bianco AE. Protective responses against skin-dwelling microfilariae of Onchocerca lienalis in severe combined immunodeficient mice. Infect Immun. 1997;65(7):2846-51.
13. Bianco AE, Nwachukwu MA, Townson S, Doenhoff MJ, Muller RL. Evaluation of drugs against Onchocerca microfiliariae in an inbred mouse model. Trop Med Parasitol. 1986;37(1):39-45.
14. Morales-Hojas R, Cheke RA, Post RJ. Molecular systematics of five Onchocerca species (Nematoda: Filarioidea) including the human parasite, O. volvulus, suggest sympatric speciation. J Helminthol. 2006;80(3):281-90.
15. Cho-Ngwa F, Abongwa M, Ngemenya MN, Nyongbela KD. Selective activity of extracts of Margaritaria discoidea and Homalium africanum on Onchocerca ochengi. BMC Complement Altern Med. 2010;10:62. doi:10.1186/1472-6882-10-62.
16. Bulman CA, Bidlow CM, Lustigman S, Cho-Ngwa F, Williams D, Rascón JAA, et al. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis. PLoS Negl Trop Dis. 2015;9(2):e0003534. doi:10. 1371/journal.pntd.0003534.
17. Samje M, Metuge J, Mbah J, Nguesson B, Cho-Ngwa F. In vitro anti-Onchocerca ochengi activities of extracts and chromatographic fractions of Craterispermum laurinum and Morinda lucida. BMC Complement Altern Med. 2014;14:325. doi:10.1186/1472-6882-14-325.
18. Metuge JA, Babiaka SB, Mbah JA, Ntie-Kang F, Ayimele GA, Cho-Ngwa F. Anti-onchocerca metabolites from Cyperus articulatus: Isolation, in vitro activity and in silico 'drug-likeness'. Nat Prod Bioprospect. 2014;4(4):243-9. doi:10.1007/s13659-014-0023-5.
19. Dec Bronsvoort BM, Makepeace BL, Renz A, Tanya VN, Fleckenstein L, Ekale D, et al. UMF-078: a modified flubendazole with potent macrofilaricidal activity against Onchocerca ochengi in African cattle. Parasit Vectors. 2008;1(1):18. doi: 10.1186/1756-3305-1-18.
20. Gilbert J, Nfon CK, Makepeace BL, Njongmeta LM, Hastings IM, Pfarr KM, et al. antibiotic chemotherapy of onchocerciasis: in a bovine model, killing of adult parasites requires a sustained depletion of endosymbiotic bacteria (Wolbachia species). J Infect Dis. 2005;192(8):1483-93. doi:10.1086/462426.
21. Trees AJ, Graham SP, Renz A, Bianco AE, Tanya V. Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments. Parasitology. 2000;120(Suppl):S133-42.
22. Wildenburg G, Plenge-Bonig A, Renz A, Fischer P, Buttner DW. Distribution of mast cells and their correlation with inflammatory cells around Onchocerca gutturosa, O. tarsicola, O. ochengi, and O. flexuosa. Parasitol Res. 1997;83(2):109-20.
23. McCall PJ, Townson H, Trees AJ. Morphometric differentiation of Onchocerca volvulus and O. ochengi infective larvae. Trans R Soc Trop Med Hyg. 1992; 86(1):63-5.
24. Langworthy NG, Renz A, Mackenstedt U, Henkle-Duhrsen K, de Bronsvoort MB, Tanya VN, et al. Macrofilaricidal activity of tetracycline against the filarial nematode Onchocerca ochengi: elimination of Wolbachia precedes worm death and suggests a dependent relationship. Proc Biol Sci. 2000;267(1448): 1063-9. doi:10.1098/rspb.2000.1110.
25. Xie H, Bain O, Williams SA. Molecular phylogenetic studies on filarial parasites based on 5S ribosomal spacer sequences. Parasite. 1994;1(2):141-51.
26. Trees AJ. Onchocerca ochengi: mimic, model or modulator of O. volvulus? Parasitol Today. 1992;8(10):337-9. doi:10.1016/0169-4758(92)90068-D.
27. Okamoto M, Van Stry M, Chung L, Koyanagi M, Sun X, Suzuki Y, et al. Mina, an Il4 repressor, controls T helper type 2 bias. Nat Immunol. 2009;10(8):872-9. doi:10.1038/ni.1747.
28. Paul WE, Zhu J. How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol. 2010;10(4):225-35. doi:10.1038/nri2735.
29. Tendongfor N, Wanji S, Ngwa JC, Esum ME, Specht S, Enyong P, et al. The human parasite Loa loa in cytokine and cytokine receptor gene knock out BALB/c mice: survival, development and localization. Parasit Vectors. 2012;5:43. doi:10.1186/1756-3305-5-43.
30. Allen JE, Adjei O, Bain O, Hoerauf A, Hoffmann WH, Makepeace BL, et al. Of mice, cattle, and humans: the immunology and treatment of river blindness. PLoS Negl Trop Dis. 2008;2(4):e217.
31. Volkmann L, Bain O, Saeftel M, Specht S, Fischer K, Brombacher F, et al. Murine filariasis: interleukin 4 and interleukin 5 lead to containment of different worm developmental stages. Med Microbiol Immunol. 2003;192(1): 23-31. doi:10.1007/s00430-002-0155-9.
32. Halliday A, Guimaraes A, Tyrer H, Metuge H, Patrick C, Arnaud K-O, et al. A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis. Parasit Vectors. 2014;7(1):1-14. doi:10.1186/s13071-014-0472-z.